RaQualia Pharma Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Hirobumi Takeuchi
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 3.2yrs |
CEO ownership | 0.05% |
Management average tenure | no data |
Board average tenure | 3.2yrs |
CEO
Hirobumi Takeuchi (52 yo)
3.2yrs
Tenure
Mr. Hirobumi Takeuchi is President & Chairman of the Board of RaQualia Pharma Inc. from March 2021. He joined the RaQualia Pharma Inc. in March 2021. He served as the Chief Financial Officer at Skylight Bi...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Chairman of the Board | 3.3yrs | no data | 0.052% ¥ 6.8m | |
Executive Officer & Director | 2.2yrs | no data | 0.078% ¥ 10.1m | |
VP & Director | 2.2yrs | no data | 0.039% ¥ 5.1m | |
Independent Outside Director | 3.2yrs | no data | 11.02% ¥ 1.4b | |
Independent Outside Director | 4.2yrs | no data | no data | |
Independent Outside Director | 3.3yrs | no data | no data | |
Independent Outside Director | 3.2yrs | no data | no data |
3.2yrs
Average Tenure
52yo
Average Age
Experienced Board: 4579's board of directors are considered experienced (3.2 years average tenure).